NEW
ECTRIMS 2021
Biogen
Check out our events @ECTRIMS 2021 by clicking on the program below.
SYMPOSIUM
Advancing MS care: New treatments and technologies
TYSABRI Product Theatre
Subcutaneous Natalizumab
TECFIDERA Product Theatre
Shaping clinical practice from trial data
BRAIN EXCHANGE
Treatment sequencing in the context of Covid-19 pandemic
BRAIN EXCHANGE
Underserved populations
BRAIN EXCHANGE
Digital health
TYSABRI LATE BREAKING NEWS
Primary results of NOVA
STRATEGIES FOR LIFE IN MULTIPLECHOICES
Biogen-128199.
Date of preparation: September 2021.